67 related articles for article (PubMed ID: 6872413)
1. Dose proportionality of amrinone.
Edelson J; Park GB; Angellotti J; Kershner RP; Ryan JJ; McMahon FG
Clin Pharmacol Ther; 1983 Aug; 34(2):190-4. PubMed ID: 6872413
[TBL] [Abstract][Full Text] [Related]
2. Oral bioavailability and intravenous pharmacokinetics of amrinone in humans.
Park GB; Kershner RP; Angellotti J; Williams RL; Benet LZ; Edelson J
J Pharm Sci; 1983 Jul; 72(7):817-9. PubMed ID: 6886991
[TBL] [Abstract][Full Text] [Related]
3. Amrinone metabolism.
Kullberg MP; Freeman GB; Biddlecome C; Alousi AA; Edelson J
Clin Pharmacol Ther; 1981 Mar; 29(3):394-401. PubMed ID: 7471610
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of the bipyridines amrinone and milrinone.
Edelson J; Stroshane R; Benziger DP; Cody R; Benotti J; Hood WB; Chatterjee K; Luczkowec C; Krebs C; Schwartz R
Circulation; 1986 Mar; 73(3 Pt 2):III145-52. PubMed ID: 3510771
[TBL] [Abstract][Full Text] [Related]
5. Relationship between amrinone plasma concentration and cardiac index.
Edelson J; LeJemtel TH; Alousi AA; Biddlecome CE; Maskin CS; Sonnenblick EH
Clin Pharmacol Ther; 1981 Jun; 29(6):723-8. PubMed ID: 7226703
[TBL] [Abstract][Full Text] [Related]
6. Effect of the acetylator phenotype on amrinone pharmacokinetics.
Hamilton RA; Kowalsky SF; Wright EM; Cernak P; Benziger DP; Stroshane RM; Edelson J
Clin Pharmacol Ther; 1986 Dec; 40(6):615-9. PubMed ID: 3780123
[TBL] [Abstract][Full Text] [Related]
7. Age-related amrinone pharmacokinetics in a pediatric population.
Allen-Webb EM; Ross MP; Pappas JB; McGough EC; Banner W
Crit Care Med; 1994 Jun; 22(6):1016-24. PubMed ID: 8205809
[TBL] [Abstract][Full Text] [Related]
8. The relationship between the pharmacokinetics of amrinone in the marmoset and platelet effects.
Eason CT; Usansky JI; Henry GP; Powles P; Bonner FW
Eur J Drug Metab Pharmacokinet; 1988; 13(2):129-33. PubMed ID: 3145204
[TBL] [Abstract][Full Text] [Related]
9. Dose-related cardiovascular effects of amrinone during enflurane anesthesia in the dog.
Makela VH; Kapur PA
Anesth Analg; 1986 Aug; 65(8):849-52. PubMed ID: 3729021
[TBL] [Abstract][Full Text] [Related]
10. Amrinone. A preliminary review of its pharmacological properties and therapeutic use.
Ward A; Brogden RN; Heel RC; Speight TM; Avery GS
Drugs; 1983 Dec; 26(6):468-502. PubMed ID: 6360634
[TBL] [Abstract][Full Text] [Related]
11. Amrinone in severe congestive heart failure: another look at an intriguing new cardioactive drug.
Hermiller JB; Leithe ME; Magorien RD; Unverferth DV; Leier CV
J Pharmacol Exp Ther; 1984 Feb; 228(2):319-26. PubMed ID: 6694112
[TBL] [Abstract][Full Text] [Related]
12. [Experimental and clinical pharmacokinetics of amrinone].
Padrini R; Miglioli PA; Casiglia E; Piovan D; Ferrari M
Cardiologia; 1982; 27(1):103-6. PubMed ID: 6927443
[No Abstract] [Full Text] [Related]
13. Isotretinoin kinetics after 80 to 320 mg oral doses.
Colburn WA; Gibson DM
Clin Pharmacol Ther; 1985 Apr; 37(4):411-4. PubMed ID: 3856501
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and hemodynamics of amrinone in patients with chronic cardiac failure of diverse etiology.
Wilson H; Rocci ML; Weber KT; Andrews V; Likoff MJ
Res Commun Chem Pathol Pharmacol; 1987 Apr; 56(1):3-19. PubMed ID: 3589153
[TBL] [Abstract][Full Text] [Related]
15. Absorption kinetics of orally administered leucovorin calcium.
McGuire BW; Sia LL; Haynes JD; Kisicki JC; Gutierrez ML; Stokstad EL
NCI Monogr; 1987; (5):47-56. PubMed ID: 3501546
[TBL] [Abstract][Full Text] [Related]
16. Hemodynamic effects of intravenous and oral amrinone in patients with severe heart failure: relationship between intravenous and oral administration.
LeJemtel TH; Keung EC; Schwartz WJ; Maskin CS; Greenberg MA; Davis RS; Forman R; Ribner HS; Sonnenblick EH
Trans Assoc Am Physicians; 1979; 92():325-33. PubMed ID: 549256
[No Abstract] [Full Text] [Related]
17. The effects of amrinone on cardiac function, oxygen consumption and lactate production of an isolated, perfused, working guinea-pig heart.
Zannad F; Juillere Y; Royer RJ
Arch Int Pharmacodyn Ther; 1983 Jun; 263(2):264-71. PubMed ID: 6882099
[TBL] [Abstract][Full Text] [Related]
18. Amrinone: a promising new cardiotonic agent in the treatment of chronic cardiac failure.
Likoff MJ; Weber KT; Andrews V; Janicki JS
Herz; 1983 Aug; 8(4):199-205. PubMed ID: 6413341
[No Abstract] [Full Text] [Related]
19. In vitro electrophysiologic properties of amrinone in mammalian cardiac tissue.
Piwonka RW; Canniff PC; Farah AE
J Cardiovasc Pharmacol; 1983; 5(6):1058-67. PubMed ID: 6196555
[TBL] [Abstract][Full Text] [Related]
20. A pharmacokinetic comparison of single doses of once-daily cyclobenzaprine extended-release 15 mg and 30 mg: a randomized, double-blind, two-period crossover study in healthy volunteers.
Darwish M; Chang S; Hellriegel ET
Clin Ther; 2009 Jan; 31(1):108-14. PubMed ID: 19243711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
